Notable Analyst Rating Changes 05/09: (STJ) (ARNA) (UA) Upgraded; (AET) (MRVL) (HLF) Downgraded
Tweet
Share
E-mail
Get Alerts STJ Hot Sheet
Join SI Premium – FREE
UPGRADES
Morgan Stanley upgrades St. Jude Medical (NYSE: STJ) from Equal Weight to Overweight.
BMO Capital lifts Arena Pharma (Nasdaq: ARNA) from Market Perform to Outperform, boosting its price target from $1 to $7.
UBS raises Under Armour, Inc. (NYSE: UA) from Neutral to Buy.
Morgan Stanley ups Dow Chemical (NYSE: DOW) from Equal Weight to Overweight with a price target of $38 (up from $35).
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Goldman Sachs trims Aetna (NYSE: AET) from Neutral to Sell with a price target of $45 (down from $50). Click Here for more color.
UBS lowers Marvell (Nasdaq: MRVL) from Buy to Neutral, price target cut from $18 to $14.
Caris & Co chops Herbalife (NYSE: HLF) from Buy to Average Wednesday morning. Her price target was slashed sharply from $86 to just $39. Click Here for more color.
UBS reduces Analog Devices (NYSE: ADI) from Buy to Neutral, its price target lowered from $45 to $40. Click Here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Credit Suisse initiates Phillips 66 (NYSE: PSX) with an Outperform and $42 price target.
Needham & Company commences Jive Software (Nasdaq: JIVE) with a Hold. Click Here for more color.
Citi begins Zynga (Nasdaq: ZNGA) with a Buy and price target of $12.
ThinkEquity starts Ctrip.com (Nasdaq: CTRP) with a Hold rating and a $21 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Morgan Stanley upgrades St. Jude Medical (NYSE: STJ) from Equal Weight to Overweight.
BMO Capital lifts Arena Pharma (Nasdaq: ARNA) from Market Perform to Outperform, boosting its price target from $1 to $7.
UBS raises Under Armour, Inc. (NYSE: UA) from Neutral to Buy.
Morgan Stanley ups Dow Chemical (NYSE: DOW) from Equal Weight to Overweight with a price target of $38 (up from $35).
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Goldman Sachs trims Aetna (NYSE: AET) from Neutral to Sell with a price target of $45 (down from $50). Click Here for more color.
UBS lowers Marvell (Nasdaq: MRVL) from Buy to Neutral, price target cut from $18 to $14.
Caris & Co chops Herbalife (NYSE: HLF) from Buy to Average Wednesday morning. Her price target was slashed sharply from $86 to just $39. Click Here for more color.
UBS reduces Analog Devices (NYSE: ADI) from Buy to Neutral, its price target lowered from $45 to $40. Click Here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Credit Suisse initiates Phillips 66 (NYSE: PSX) with an Outperform and $42 price target.
Needham & Company commences Jive Software (Nasdaq: JIVE) with a Hold. Click Here for more color.
Citi begins Zynga (Nasdaq: ZNGA) with a Buy and price target of $12.
ThinkEquity starts Ctrip.com (Nasdaq: CTRP) with a Hold rating and a $21 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- SPS Commerce (SPSC) PT Raised to $100 at Needham
- NIQ Global Intelligence Plc (NIQ) PT Raised to $21 at Needham
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Credit Suisse, UBS, Citi, Morgan Stanley, Needham & Company, ThinkEquity, BMO Capital, Notable Analyst Rating ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
